Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $58,170 | 2,405 | 61.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,121 | 38 | 37.0% |
| Consulting Fee | $1,536 | 2 | 1.6% |
| Education | $208.87 | 25 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $38,370 | 300 | $0 (2024) |
| Amgen Inc. | $13,266 | 202 | $0 (2024) |
| Amarin Pharma Inc. | $3,959 | 165 | $0 (2023) |
| GlaxoSmithKline, LLC. | $3,861 | 153 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,094 | 114 | $0 (2024) |
| ABBVIE INC. | $2,952 | 145 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,594 | 185 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,021 | 89 | $0 (2024) |
| PFIZER INC. | $1,995 | 85 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $1,829 | 73 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,164 | 229 | AstraZeneca Pharmaceuticals LP ($1,523) |
| 2023 | $6,910 | 265 | AstraZeneca Pharmaceuticals LP ($1,375) |
| 2022 | $8,363 | 311 | Amgen Inc. ($1,824) |
| 2021 | $15,478 | 370 | Amgen Inc. ($6,910) |
| 2020 | $9,016 | 325 | AstraZeneca Pharmaceuticals LP ($4,058) |
| 2019 | $13,082 | 329 | AstraZeneca Pharmaceuticals LP ($6,340) |
| 2018 | $12,159 | 315 | AstraZeneca Pharmaceuticals LP ($5,030) |
| 2017 | $23,865 | 326 | AstraZeneca Pharmaceuticals LP ($16,448) |
All Payment Transactions
2,470 individual payment records from CMS Open Payments — Page 1 of 99
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: PAIN | ||||||
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Diabetes | ||||||
| 12/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Endocrinology | ||||||
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: UROLOGY | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: PAIN | ||||||
| 11/25/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $16.74 | General |
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $8.11 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,054 | 9,815 | $948,800 | $456,779 |
| 2022 | 36 | 4,286 | 9,947 | $995,405 | $488,268 |
| 2021 | 34 | 4,160 | 9,492 | $992,105 | $483,168 |
| 2020 | 39 | 3,653 | 8,057 | $728,852 | $379,946 |
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 539 | 2,777 | $416,550 | $203,732 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 346 | 732 | $127,750 | $76,790 | 60.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 256 | 256 | $40,960 | $36,692 | 89.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 269 | 269 | $26,900 | $23,603 | 87.7% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2023 | 84 | 670 | $33,500 | $17,137 | 51.2% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 84 | 670 | $33,500 | $12,905 | 38.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 114 | 114 | $39,900 | $8,100 | 20.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 281 | 281 | $16,860 | $7,919 | 47.0% |
| 97161 | Evaluation for physical therapy, typically 20 minutes | Office | 2023 | 80 | 80 | $9,600 | $7,028 | 73.2% |
| 97035 | Application of ultrasound, each 15 minutes | Office | 2023 | 84 | 670 | $16,750 | $6,267 | 37.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 280 | 280 | $11,200 | $5,907 | 52.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 260 | 260 | $10,400 | $5,486 | 52.8% |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 2023 | 84 | 666 | $59,940 | $5,274 | 8.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 143 | 144 | $4,320 | $4,324 | 100.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 18 | $5,400 | $4,323 | 80.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 165 | 335 | $13,400 | $3,972 | 29.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 72 | 83 | $6,205 | $3,748 | 60.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 70 | 70 | $7,000 | $3,239 | 46.3% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 142 | 142 | $5,680 | $2,905 | 51.1% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 40 | 55 | $5,500 | $2,609 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 217 | 298 | $5,960 | $2,503 | 42.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $4,375 | $2,490 | 56.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $2,400 | $2,186 | 91.1% |
| 97164 | Re-evaluation for physical therapy, typically 20 minutes | Office | 2023 | 25 | 30 | $2,700 | $1,882 | 69.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 74 | 74 | $8,880 | $1,688 | 19.0% |
About Dr. Nick Lee, MD
Dr. Nick Lee, MD is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598881179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nick Lee, MD has received a total of $95,037 in payments from pharmaceutical and medical device companies, with $6,164 received in 2024. These payments were reported across 2,470 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($58,170).
As a Medicare-enrolled provider, Lee has provided services to 16,153 Medicare beneficiaries, totaling 37,311 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Los Angeles, CA
- Active Since 03/22/2007
- Last Updated 05/08/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598881179
Products in Payments
- FARXIGA (Drug) $31,364
- Otezla (Drug) $8,455
- Vascepa (Drug) $3,959
- BYDUREON (Drug) $2,130
- JARDIANCE (Drug) $2,029
- TRELEGY ELLIPTA (Drug) $1,688
- ENTRESTO (Drug) $1,461
- Aimovig (Biological) $1,288
- EVENITY (Biological) $1,261
- Linzess (Drug) $1,198
- BREZTRI (Drug) $1,180
- XIFAXAN (Drug) $1,168
- Repatha (Biological) $1,120
- VRAYLAR (Drug) $1,058
- SYMBICORT (Drug) $1,015
- ANORO (Drug) $891.34
- Prolia (Biological) $858.73
- XARELTO (Drug) $836.29
- ELIQUIS (Drug) $827.89
- LINZESS (Drug) $814.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Thomas Magee, Md, MD
Internal Medicine — Payments: $1.2M
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666